Literature DB >> 12672583

Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis.

Juan Carlos Rodriguez Díaz1, M Ruiz, M López, G Royo.   

Abstract

We evaluated the in vitro activity against Mycobacterium tuberculosis of the combination of fluoroquinolones and linezolid with classical drugs. The combination of isoniazid with fluoroquinolones had synergic activity in nine of the ten isoniazid-susceptible strains. We also found synergism between rifampicin and linezolid in five of the 15 strains susceptible to rifampicin. The clinical significance of these findings should be evaluated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672583     DOI: 10.1016/s0924-8579(02)00387-4

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  3 in total

1.  Pharmacotherapy for multidrug resistant tuberculosis.

Authors:  Naveen Chhabra; M L Aseri; Ramakant Dixit; S Gaur
Journal:  J Pharmacol Pharmacother       Date:  2012-04

2.  Successful Treatment of Disseminated Bacillus Calmette-Guérin Disease in an HIV-Infected Child with a Linezolid-Containing Regimen.

Authors:  Srđan Roglić; Drusia Dickson; Branko Miše; Klaudija Višković; Vera Katalinić-Janković; George Rutherford; Josip Begovac
Journal:  Case Rep Infect Dis       Date:  2016-10-10

3.  Update on the appropriate use of linezolid in clinical practice.

Authors:  Roberto Manfredi
Journal:  Ther Clin Risk Manag       Date:  2006-12       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.